News
$IGC - IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
Sep 28, 2026 · ThinkSabio Blog
$IGC - IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
28-SEP-2026 08:00 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
